A Phase I randomized, double-blind, placebo-controlled,

Project: Research project

Project Details

Description

A Phase I randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and immunogenicity of the GSK Biologicals herpes zoster vaccine, gE/AS01B, when administered in 3 doses versus 2 doses and versus placebo in autologous hemat
StatusFinished
Effective start/end date2/6/098/21/12

Funding

  • GlaxoSmithKline

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.